Royal Bank Of Canada Has Lowered Expectations for Cigna Group (NYSE:CI) Stock Price

Cigna Group (NYSE:CI) had its target price reduced by stock analysts at Royal Bank Of Canada from $344.00 to $333.00 in a report released on Friday,MarketScreener reports. The brokerage presently has an “outperform” rating on the health services provider’s stock. Royal Bank Of Canada’s price target indicates a potential upside of 14.64% from the stock’s current price.

Several other equities analysts have also recently weighed in on the company. Wells Fargo & Company lowered their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. Sanford C. Bernstein reiterated a “market perform” rating and set a $307.00 price target on shares of Cigna Group in a research note on Tuesday, January 6th. Barclays set a $303.00 price objective on Cigna Group and gave the company an “overweight” rating in a research note on Friday. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Finally, Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $323.16.

Cigna Group Trading Up 2.1%

NYSE:CI opened at $290.48 on Friday. The stock has a market cap of $77.60 billion, a price-to-earnings ratio of 12.73, a price-to-earnings-growth ratio of 0.96 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The business’s 50-day simple moving average is $274.47 and its 200 day simple moving average is $283.96. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the previous year, the company posted $6.64 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Pathway Financial Advisers LLC grew its position in Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after acquiring an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. increased its stake in shares of Cigna Group by 17.7% in the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares during the period. HM Payson & Co. boosted its position in Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after buying an additional 35 shares during the period. Carr Financial Group Corp increased its position in Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after acquiring an additional 36 shares during the period. Finally, Natural Investments LLC increased its position in Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 36 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 results beat expectations — Cigna reported adjusted Q4 EPS of $8.08 and revenue of $72.5B (both ahead of Street estimates), driven by Evernorth growth and higher specialty volumes; the strong quarter underpins the market rally. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Positive Sentiment: FTC settlement with Express Scripts removes regulatory uncertainty and commits to reforms (including measures to lower insulin costs) — investors appear to view this as a de‑risking event for the PBM unit. Cigna settles FTC insulin case, commits overhauling drug pricing
• Positive Sentiment: Dividend increase — the board raised the quarterly payout to $1.56 (a ~3.3% raise), supporting income investors and signaling confidence in cash flow. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Positive Sentiment: Solid full‑year results — 2025 net income roughly $6B and double‑digit revenue growth highlight operational momentum across businesses. Cigna posts US$6 billion profit on double‑digit 2025 revenue growth
• Neutral Sentiment: Company set FY‑2026 EPS target of at least $30.25 — management established an outlook but it is a baseline that leaves room for variability given cost dynamics. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Neutral Sentiment: Analysts growing cautious on near‑term growth and valuation despite the beat — some coverage flags a tighter multiple if cost pressures persist. A Look At Cigna Group (CI) Valuation As Analysts Turn Cautious On Near Term Growth
• Negative Sentiment: Guidance and cost headwinds — Reuters and others note Cigna’s 2026 forecast came in below some Street expectations and management flagged continued medical cost and margin pressure, which could cap upside. Cigna 2026 forecast misses Wall Street expectations
• Negative Sentiment: Operational headwinds — elevated costs and fewer medical customers were noted as offsets to growth, which investors will watch in coming quarters. Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.